The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Hospital and Health System Compounding Under the Federal Food, Drug, and Cosmetic Act



This guidance describes how FDA intends to apply section 503A of the FD&C Act to drugs compounded by licensed pharmacists or physicians in state-licensed hospital or health system pharmacies for use within the hospital or health system.

Go back

GMP Conferences by Topics